| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carbon Monoxide | 95 | 2023 | 531 | 14.750 |
Why?
|
| Heme Oxygenase-1 | 54 | 2021 | 381 | 7.310 |
Why?
|
| Heme Oxygenase (Decyclizing) | 39 | 2021 | 171 | 2.840 |
Why?
|
| Heme | 9 | 2023 | 307 | 2.260 |
Why?
|
| Biliverdine | 10 | 2014 | 29 | 1.570 |
Why?
|
| Bilirubin | 10 | 2019 | 424 | 1.390 |
Why?
|
| Hyperoxia | 14 | 2020 | 262 | 1.230 |
Why?
|
| Macrophages | 26 | 2019 | 5655 | 1.170 |
Why?
|
| Apyrase | 5 | 2019 | 364 | 1.170 |
Why?
|
| Membrane Proteins | 22 | 2021 | 7873 | 0.970 |
Why?
|
| Wounds and Injuries | 7 | 2022 | 2400 | 0.960 |
Why?
|
| Reperfusion Injury | 13 | 2018 | 1025 | 0.900 |
Why?
|
| Mitochondria | 14 | 2022 | 3520 | 0.900 |
Why?
|
| Neutrophils | 16 | 2023 | 3711 | 0.870 |
Why?
|
| Muscle, Smooth, Vascular | 7 | 2021 | 1504 | 0.850 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 4 | 2019 | 167 | 0.850 |
Why?
|
| Nitric Oxide | 13 | 2022 | 2128 | 0.830 |
Why?
|
| Animals | 145 | 2023 | 168561 | 0.770 |
Why?
|
| Poisons | 1 | 2021 | 34 | 0.760 |
Why?
|
| Period Circadian Proteins | 2 | 2018 | 102 | 0.750 |
Why?
|
| Cytoprotection | 6 | 2012 | 210 | 0.740 |
Why?
|
| Neointima | 1 | 2021 | 135 | 0.740 |
Why?
|
| Inflammation | 22 | 2022 | 10578 | 0.730 |
Why?
|
| Apoptosis | 32 | 2017 | 9715 | 0.730 |
Why?
|
| PPAR gamma | 3 | 2012 | 493 | 0.720 |
Why?
|
| Arteriosclerosis | 2 | 2021 | 1092 | 0.720 |
Why?
|
| Reactive Oxygen Species | 11 | 2022 | 2077 | 0.720 |
Why?
|
| Immunity, Innate | 7 | 2019 | 2956 | 0.710 |
Why?
|
| Myocytes, Smooth Muscle | 4 | 2021 | 686 | 0.700 |
Why?
|
| Circadian Clocks | 1 | 2021 | 171 | 0.660 |
Why?
|
| Superoxides | 2 | 2019 | 386 | 0.650 |
Why?
|
| Lipopolysaccharides | 20 | 2014 | 2211 | 0.650 |
Why?
|
| Muscular Atrophy | 1 | 2021 | 350 | 0.620 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2021 | 555 | 0.610 |
Why?
|
| Physical Conditioning, Animal | 1 | 2021 | 362 | 0.600 |
Why?
|
| Mice | 77 | 2023 | 81045 | 0.590 |
Why?
|
| Mice, Inbred C57BL | 39 | 2021 | 21821 | 0.590 |
Why?
|
| Lung | 26 | 2017 | 9826 | 0.580 |
Why?
|
| Aorta, Thoracic | 1 | 2021 | 1080 | 0.500 |
Why?
|
| Chemotaxis | 5 | 2022 | 607 | 0.490 |
Why?
|
| Protective Agents | 2 | 2007 | 156 | 0.480 |
Why?
|
| Lung Injury | 7 | 2020 | 436 | 0.480 |
Why?
|
| Nitric Oxide Synthase Type II | 7 | 2019 | 534 | 0.470 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2014 | 111 | 0.460 |
Why?
|
| Nitric Oxide Synthase Type III | 3 | 2011 | 689 | 0.460 |
Why?
|
| Cell Proliferation | 13 | 2016 | 10472 | 0.460 |
Why?
|
| Liver Regeneration | 2 | 2013 | 210 | 0.450 |
Why?
|
| Bacterial Infections | 1 | 2021 | 1389 | 0.450 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2018 | 627 | 0.440 |
Why?
|
| Cells, Cultured | 30 | 2021 | 19223 | 0.440 |
Why?
|
| Mice, Knockout | 20 | 2021 | 14554 | 0.440 |
Why?
|
| Cell Differentiation | 5 | 2021 | 11470 | 0.440 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2011 | 561 | 0.430 |
Why?
|
| Antigens, CD | 4 | 2022 | 4024 | 0.420 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2017 | 1016 | 0.420 |
Why?
|
| Signal Transduction | 25 | 2022 | 23387 | 0.420 |
Why?
|
| Oxidative Stress | 9 | 2019 | 3081 | 0.410 |
Why?
|
| Enzyme Induction | 11 | 2018 | 475 | 0.410 |
Why?
|
| Antimetabolites | 2 | 2009 | 125 | 0.410 |
Why?
|
| Nitric Oxide Synthase | 8 | 2009 | 916 | 0.400 |
Why?
|
| Acute Lung Injury | 4 | 2018 | 378 | 0.400 |
Why?
|
| Homeostasis | 5 | 2010 | 3335 | 0.400 |
Why?
|
| Mitochondrial Proteins | 3 | 2020 | 995 | 0.400 |
Why?
|
| Hepatectomy | 2 | 2013 | 550 | 0.390 |
Why?
|
| Sumoylation | 1 | 2011 | 83 | 0.390 |
Why?
|
| MAP Kinase Signaling System | 8 | 2012 | 1525 | 0.380 |
Why?
|
| Bone Marrow Transplantation | 3 | 2021 | 2763 | 0.380 |
Why?
|
| Gene Expression | 10 | 2017 | 7790 | 0.380 |
Why?
|
| Delayed Graft Function | 1 | 2010 | 48 | 0.380 |
Why?
|
| Shock, Septic | 7 | 2005 | 773 | 0.370 |
Why?
|
| Interleukin-10 | 12 | 2015 | 1200 | 0.370 |
Why?
|
| Gene Expression Regulation, Enzymologic | 6 | 2013 | 1213 | 0.370 |
Why?
|
| Colitis | 5 | 2022 | 1149 | 0.370 |
Why?
|
| Rats, Sprague-Dawley | 25 | 2015 | 8300 | 0.360 |
Why?
|
| Liver | 11 | 2018 | 7470 | 0.360 |
Why?
|
| Hemorrhage | 2 | 2021 | 3461 | 0.350 |
Why?
|
| Islets of Langerhans Transplantation | 3 | 2012 | 744 | 0.350 |
Why?
|
| Inflammasomes | 1 | 2014 | 493 | 0.350 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 3 | 2004 | 647 | 0.350 |
Why?
|
| Anti-Infective Agents | 3 | 2023 | 971 | 0.340 |
Why?
|
| Carotid Artery Injuries | 1 | 2010 | 96 | 0.340 |
Why?
|
| Receptors, Formyl Peptide | 3 | 2020 | 145 | 0.330 |
Why?
|
| Organ Transplantation | 3 | 2015 | 1135 | 0.330 |
Why?
|
| Rats | 40 | 2015 | 24265 | 0.330 |
Why?
|
| Adenosine | 2 | 2019 | 823 | 0.330 |
Why?
|
| Immune Tolerance | 3 | 2015 | 2257 | 0.320 |
Why?
|
| Kidney Diseases | 2 | 2018 | 2145 | 0.310 |
Why?
|
| Stem Cells | 1 | 2021 | 3563 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2014 | 2502 | 0.300 |
Why?
|
| Administration, Inhalation | 14 | 2016 | 1104 | 0.300 |
Why?
|
| Gases | 6 | 2022 | 197 | 0.290 |
Why?
|
| Myocardial Ischemia | 2 | 2016 | 2145 | 0.290 |
Why?
|
| Mitogen-Activated Protein Kinases | 10 | 2003 | 1284 | 0.290 |
Why?
|
| Adenosine Triphosphate | 6 | 2022 | 2024 | 0.290 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2007 | 124 | 0.290 |
Why?
|
| Receptor, Anaphylatoxin C5a | 2 | 2019 | 90 | 0.290 |
Why?
|
| Electron Transport Complex IV | 1 | 2007 | 189 | 0.290 |
Why?
|
| Ion Channels | 1 | 2011 | 1056 | 0.280 |
Why?
|
| Ischemic Preconditioning | 1 | 2007 | 92 | 0.280 |
Why?
|
| Cell-Derived Microparticles | 2 | 2019 | 168 | 0.280 |
Why?
|
| Phagocytosis | 3 | 2015 | 1538 | 0.280 |
Why?
|
| Endotoxins | 4 | 2019 | 525 | 0.280 |
Why?
|
| Lung Diseases | 6 | 2006 | 1884 | 0.280 |
Why?
|
| Pneumonia, Bacterial | 2 | 2021 | 316 | 0.280 |
Why?
|
| Hemoglobins | 6 | 2018 | 1532 | 0.280 |
Why?
|
| Graft Survival | 5 | 2012 | 3733 | 0.280 |
Why?
|
| Oxidants | 2 | 2003 | 164 | 0.270 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 7 | 2016 | 697 | 0.270 |
Why?
|
| Disease Models, Animal | 22 | 2021 | 18006 | 0.270 |
Why?
|
| Cardiopulmonary Bypass | 4 | 2017 | 1066 | 0.270 |
Why?
|
| Prodrugs | 3 | 2018 | 268 | 0.270 |
Why?
|
| Circadian Rhythm | 1 | 2017 | 2623 | 0.260 |
Why?
|
| Respiratory Burst | 2 | 2023 | 113 | 0.260 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2002 | 2276 | 0.260 |
Why?
|
| Tumor Necrosis Factor-alpha | 13 | 2012 | 4414 | 0.260 |
Why?
|
| Cytokines | 13 | 2020 | 7317 | 0.260 |
Why?
|
| Oxygen | 13 | 2023 | 4169 | 0.260 |
Why?
|
| Cyclic GMP | 8 | 2013 | 408 | 0.250 |
Why?
|
| Sepsis | 5 | 2021 | 2589 | 0.250 |
Why?
|
| Bronchoalveolar Lavage Fluid | 9 | 2017 | 766 | 0.250 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 2018 | 209 | 0.250 |
Why?
|
| PPAR alpha | 1 | 2006 | 196 | 0.250 |
Why?
|
| DNA, Mitochondrial | 4 | 2023 | 814 | 0.250 |
Why?
|
| Kidney | 3 | 2018 | 7167 | 0.250 |
Why?
|
| Humans | 92 | 2023 | 742088 | 0.240 |
Why?
|
| Cell Cycle | 3 | 2011 | 2964 | 0.240 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 11 | 2017 | 4751 | 0.230 |
Why?
|
| Guanylate Cyclase | 8 | 2013 | 201 | 0.230 |
Why?
|
| Transcription Factor AP-1 | 6 | 2011 | 317 | 0.230 |
Why?
|
| Aorta | 2 | 2010 | 2057 | 0.230 |
Why?
|
| Myocardium | 2 | 2016 | 4775 | 0.230 |
Why?
|
| Energy Metabolism | 3 | 2013 | 2896 | 0.230 |
Why?
|
| Anemia, Sickle Cell | 4 | 2018 | 1017 | 0.230 |
Why?
|
| Enzyme Activation | 9 | 2022 | 3701 | 0.220 |
Why?
|
| Male | 73 | 2023 | 349538 | 0.220 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2003 | 2455 | 0.210 |
Why?
|
| Chemotaxis, Leukocyte | 3 | 2021 | 675 | 0.210 |
Why?
|
| Cell Nucleus | 1 | 2011 | 2968 | 0.210 |
Why?
|
| Cell Hypoxia | 4 | 2018 | 675 | 0.210 |
Why?
|
| Leucine Zippers | 1 | 2002 | 117 | 0.210 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2023 | 163 | 0.210 |
Why?
|
| DNA Repair | 1 | 2011 | 2042 | 0.210 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2018 | 1114 | 0.200 |
Why?
|
| Pneumonia | 4 | 2015 | 2117 | 0.200 |
Why?
|
| Liver Failure | 1 | 2003 | 240 | 0.200 |
Why?
|
| PAX7 Transcription Factor | 1 | 2021 | 53 | 0.200 |
Why?
|
| Ferrochelatase | 1 | 2021 | 46 | 0.200 |
Why?
|
| Endothelium, Vascular | 5 | 2015 | 4455 | 0.190 |
Why?
|
| 5-Aminolevulinate Synthetase | 1 | 2021 | 57 | 0.190 |
Why?
|
| Hydrogen Sulfide | 1 | 2022 | 137 | 0.190 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 2842 | 0.190 |
Why?
|
| Hepatocytes | 4 | 2019 | 1209 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 6 | 2021 | 6382 | 0.190 |
Why?
|
| Blotting, Western | 9 | 2013 | 5180 | 0.190 |
Why?
|
| MyoD Protein | 1 | 2021 | 151 | 0.190 |
Why?
|
| Systemic Inflammatory Response Syndrome | 3 | 2022 | 609 | 0.190 |
Why?
|
| Endotoxemia | 3 | 2012 | 206 | 0.190 |
Why?
|
| Transplantation Chimera | 2 | 2021 | 612 | 0.180 |
Why?
|
| Mice, Transgenic | 6 | 2019 | 9735 | 0.180 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2021 | 188 | 0.180 |
Why?
|
| DNA-Binding Proteins | 3 | 2011 | 9639 | 0.180 |
Why?
|
| Macrophage Activation | 3 | 2019 | 558 | 0.180 |
Why?
|
| Hydroxychloroquine | 1 | 2023 | 408 | 0.180 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 3444 | 0.180 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2014 | 902 | 0.180 |
Why?
|
| Gene Expression Regulation | 7 | 2021 | 12071 | 0.170 |
Why?
|
| Graft Rejection | 5 | 2010 | 4393 | 0.170 |
Why?
|
| Kidney Transplantation | 3 | 2010 | 4246 | 0.170 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 2938 | 0.170 |
Why?
|
| Cell Membrane | 1 | 2009 | 3744 | 0.170 |
Why?
|
| Exocytosis | 1 | 2021 | 353 | 0.170 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2011 | 140 | 0.170 |
Why?
|
| Neutrophil Activation | 1 | 2020 | 186 | 0.170 |
Why?
|
| Cytomegalovirus | 1 | 2023 | 730 | 0.170 |
Why?
|
| Shock, Hemorrhagic | 2 | 2015 | 220 | 0.170 |
Why?
|
| Isoenzymes | 4 | 2021 | 1725 | 0.170 |
Why?
|
| Complement C5a | 1 | 2019 | 107 | 0.170 |
Why?
|
| Ferritins | 2 | 2003 | 590 | 0.170 |
Why?
|
| Chemokines | 2 | 2022 | 954 | 0.160 |
Why?
|
| Antioxidants | 4 | 2019 | 1659 | 0.160 |
Why?
|
| Doxorubicin | 2 | 2018 | 2215 | 0.160 |
Why?
|
| Endothelial Cells | 5 | 2014 | 3455 | 0.160 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2009 | 1825 | 0.160 |
Why?
|
| Antisickling Agents | 1 | 2018 | 80 | 0.160 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2018 | 106 | 0.160 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2018 | 363 | 0.160 |
Why?
|
| Tunica Intima | 3 | 2011 | 464 | 0.160 |
Why?
|
| Intestine, Small | 5 | 2005 | 1243 | 0.160 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 890 | 0.150 |
Why?
|
| Carbon Dioxide | 1 | 2002 | 1141 | 0.150 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 2 | 2013 | 451 | 0.150 |
Why?
|
| Caveolin 1 | 1 | 2019 | 264 | 0.150 |
Why?
|
| Drug Delivery Systems | 3 | 2019 | 2217 | 0.150 |
Why?
|
| Escherichia coli | 5 | 2015 | 4214 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2022 | 4438 | 0.150 |
Why?
|
| RNA, Messenger | 12 | 2008 | 13029 | 0.150 |
Why?
|
| Blood Gas Analysis | 2 | 2017 | 381 | 0.150 |
Why?
|
| Caspases | 4 | 2004 | 928 | 0.150 |
Why?
|
| DNA | 1 | 2011 | 7289 | 0.150 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 3381 | 0.150 |
Why?
|
| CLOCK Proteins | 1 | 2017 | 87 | 0.150 |
Why?
|
| Kinetics | 4 | 2021 | 6474 | 0.150 |
Why?
|
| Cytomegalovirus Infections | 1 | 2023 | 817 | 0.150 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2013 | 404 | 0.150 |
Why?
|
| ARNTL Transcription Factors | 1 | 2017 | 98 | 0.140 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2022 | 1835 | 0.140 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2017 | 147 | 0.140 |
Why?
|
| Resuscitation | 2 | 2015 | 657 | 0.140 |
Why?
|
| Leukocytes | 4 | 2022 | 2039 | 0.140 |
Why?
|
| Swine | 7 | 2022 | 5934 | 0.140 |
Why?
|
| Up-Regulation | 8 | 2012 | 4211 | 0.130 |
Why?
|
| Cell Death | 4 | 2013 | 1695 | 0.130 |
Why?
|
| Hep G2 Cells | 2 | 2013 | 392 | 0.130 |
Why?
|
| Hypertension, Pulmonary | 1 | 2006 | 1527 | 0.130 |
Why?
|
| Cell Movement | 8 | 2017 | 5212 | 0.130 |
Why?
|
| Muscle Proteins | 1 | 2021 | 1159 | 0.130 |
Why?
|
| Peptides | 3 | 2023 | 4392 | 0.130 |
Why?
|
| Organometallic Compounds | 3 | 2014 | 665 | 0.130 |
Why?
|
| Interleukin-1 | 4 | 2003 | 1262 | 0.130 |
Why?
|
| Cell Respiration | 2 | 2014 | 200 | 0.130 |
Why?
|
| Vasospasm, Intracranial | 1 | 2017 | 206 | 0.130 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2003 | 1873 | 0.130 |
Why?
|
| Models, Animal | 3 | 2011 | 2170 | 0.130 |
Why?
|
| Locomotion | 1 | 2017 | 378 | 0.130 |
Why?
|
| Coordination Complexes | 2 | 2013 | 115 | 0.120 |
Why?
|
| Mitochondria, Heart | 1 | 2016 | 247 | 0.120 |
Why?
|
| Leucine | 2 | 1993 | 560 | 0.120 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2006 | 300 | 0.120 |
Why?
|
| Microvessels | 2 | 2018 | 544 | 0.120 |
Why?
|
| Cerebrospinal Fluid | 1 | 2017 | 534 | 0.120 |
Why?
|
| Autoantibodies | 3 | 2014 | 2036 | 0.120 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2014 | 32 | 0.120 |
Why?
|
| Carboxyhemoglobin | 5 | 2005 | 81 | 0.120 |
Why?
|
| Hemeproteins | 1 | 2014 | 62 | 0.120 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 87 | 0.120 |
Why?
|
| Phosphorylation | 10 | 2019 | 8436 | 0.120 |
Why?
|
| Flow Cytometry | 6 | 2021 | 5975 | 0.120 |
Why?
|
| Peritonitis | 2 | 1993 | 365 | 0.120 |
Why?
|
| Drug Synergism | 3 | 2013 | 1791 | 0.120 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2016 | 256 | 0.120 |
Why?
|
| Renal Replacement Therapy | 1 | 2016 | 258 | 0.120 |
Why?
|
| Interleukin-1alpha | 1 | 2014 | 84 | 0.120 |
Why?
|
| U937 Cells | 1 | 2014 | 268 | 0.120 |
Why?
|
| Immunity | 1 | 2020 | 1011 | 0.120 |
Why?
|
| Submitochondrial Particles | 1 | 2013 | 5 | 0.120 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2014 | 186 | 0.110 |
Why?
|
| Adenoviridae | 5 | 2007 | 1096 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 6 | 2018 | 1788 | 0.110 |
Why?
|
| Islets of Langerhans | 2 | 2012 | 1351 | 0.110 |
Why?
|
| B-Cell Activating Factor | 1 | 2013 | 119 | 0.110 |
Why?
|
| Immunohistochemistry | 7 | 2017 | 11363 | 0.110 |
Why?
|
| Biosynthetic Pathways | 1 | 2014 | 137 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2014 | 130 | 0.110 |
Why?
|
| Neoplasms | 4 | 2023 | 21596 | 0.110 |
Why?
|
| Bacterial Translocation | 1 | 2012 | 73 | 0.110 |
Why?
|
| Cell Line | 11 | 2019 | 15994 | 0.110 |
Why?
|
| Bradykinin | 1 | 1993 | 214 | 0.110 |
Why?
|
| Monocytes | 3 | 2021 | 2593 | 0.110 |
Why?
|
| MAP Kinase Kinase 3 | 2 | 2003 | 25 | 0.110 |
Why?
|
| NF-kappa B | 5 | 2004 | 2500 | 0.110 |
Why?
|
| Protoporphyrins | 4 | 2015 | 164 | 0.110 |
Why?
|
| Receptors, Leptin | 1 | 2014 | 356 | 0.110 |
Why?
|
| Histones | 2 | 2014 | 2597 | 0.110 |
Why?
|
| MicroRNAs | 2 | 2019 | 3731 | 0.100 |
Why?
|
| Interleukin-6 | 7 | 2012 | 3199 | 0.100 |
Why?
|
| Immune Evasion | 1 | 2015 | 360 | 0.100 |
Why?
|
| YY1 Transcription Factor | 1 | 2012 | 60 | 0.100 |
Why?
|
| Trans-Activators | 1 | 2002 | 2924 | 0.100 |
Why?
|
| NIH 3T3 Cells | 1 | 2013 | 677 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2014 | 544 | 0.100 |
Why?
|
| Macrophages, Peritoneal | 3 | 2002 | 251 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2021 | 1860 | 0.100 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 617 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2012 | 203 | 0.100 |
Why?
|
| Antigen-Antibody Complex | 1 | 2013 | 517 | 0.100 |
Why?
|
| Inflammation Mediators | 6 | 2006 | 1889 | 0.100 |
Why?
|
| Cell Membrane Permeability | 1 | 2013 | 590 | 0.100 |
Why?
|
| Monitoring, Intraoperative | 1 | 2017 | 953 | 0.100 |
Why?
|
| Tumor Microenvironment | 3 | 2023 | 3564 | 0.100 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 2133 | 0.100 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 2010 | 66 | 0.100 |
Why?
|
| Down-Regulation | 3 | 2012 | 3001 | 0.090 |
Why?
|
| Caspase 3 | 4 | 2011 | 759 | 0.090 |
Why?
|
| Autophagy | 2 | 2023 | 1301 | 0.090 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2004 | 476 | 0.090 |
Why?
|
| Salmonella typhimurium | 1 | 2012 | 351 | 0.090 |
Why?
|
| Brain | 3 | 2022 | 26343 | 0.090 |
Why?
|
| Calcium | 3 | 2018 | 5753 | 0.090 |
Why?
|
| Heat-Shock Proteins | 1 | 2014 | 822 | 0.090 |
Why?
|
| Vascular System Injuries | 1 | 2014 | 250 | 0.090 |
Why?
|
| Rats, Inbred Lew | 7 | 2005 | 1161 | 0.090 |
Why?
|
| Spider Venoms | 1 | 2010 | 44 | 0.090 |
Why?
|
| Potassium | 1 | 2014 | 1336 | 0.090 |
Why?
|
| Transfection | 4 | 2006 | 5892 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 438 | 0.090 |
Why?
|
| Natural Killer T-Cells | 1 | 2013 | 315 | 0.090 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2011 | 270 | 0.090 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2012 | 437 | 0.090 |
Why?
|
| Retinoblastoma Protein | 2 | 2012 | 701 | 0.090 |
Why?
|
| Heart Transplantation | 4 | 2005 | 3119 | 0.090 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2010 | 125 | 0.090 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2022 | 2410 | 0.090 |
Why?
|
| Metalloporphyrins | 3 | 2015 | 41 | 0.080 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 2009 | 66 | 0.080 |
Why?
|
| Pulmonary Emphysema | 1 | 2014 | 672 | 0.080 |
Why?
|
| Immunity, Cellular | 1 | 2015 | 1606 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 972 | 0.080 |
Why?
|
| Cell Polarity | 1 | 2012 | 644 | 0.080 |
Why?
|
| Enzyme Inhibitors | 7 | 2015 | 3800 | 0.080 |
Why?
|
| Blood Vessels | 2 | 2013 | 1124 | 0.080 |
Why?
|
| Cyclin A | 1 | 2008 | 60 | 0.080 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2010 | 241 | 0.080 |
Why?
|
| Vascular Diseases | 1 | 2017 | 1155 | 0.080 |
Why?
|
| Immunoglobulin G | 2 | 2013 | 4554 | 0.080 |
Why?
|
| Cystatin C | 1 | 2009 | 250 | 0.080 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2023 | 212 | 0.080 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 547 | 0.080 |
Why?
|
| Prostatic Neoplasms | 4 | 2015 | 11039 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 867 | 0.080 |
Why?
|
| Coronary Artery Bypass | 1 | 2017 | 2281 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2015 | 2986 | 0.080 |
Why?
|
| Cell Line, Tumor | 6 | 2015 | 16665 | 0.080 |
Why?
|
| Transplantation, Homologous | 3 | 2012 | 4771 | 0.080 |
Why?
|
| Crohn Disease | 2 | 2018 | 2301 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2004 | 363 | 0.080 |
Why?
|
| Cross Infection | 1 | 2017 | 1413 | 0.080 |
Why?
|
| Adenosine-5'-(N-ethylcarboxamide) | 1 | 2007 | 15 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2016 | 1057 | 0.080 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2018 | 364 | 0.080 |
Why?
|
| Antimycin A | 1 | 2007 | 30 | 0.080 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2004 | 452 | 0.080 |
Why?
|
| Muscle, Smooth | 4 | 2005 | 933 | 0.070 |
Why?
|
| Survival Analysis | 4 | 2012 | 10248 | 0.070 |
Why?
|
| Caspase 8 | 2 | 2004 | 195 | 0.070 |
Why?
|
| HeLa Cells | 1 | 2013 | 3127 | 0.070 |
Why?
|
| Trophoblasts | 1 | 2008 | 215 | 0.070 |
Why?
|
| RNA, Small Interfering | 4 | 2018 | 3504 | 0.070 |
Why?
|
| Acute Kidney Injury | 1 | 2019 | 1967 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2021 | 21719 | 0.070 |
Why?
|
| Cell Survival | 5 | 2013 | 5872 | 0.070 |
Why?
|
| Tacrolimus | 1 | 2010 | 741 | 0.070 |
Why?
|
| Mice, Nude | 1 | 2013 | 3689 | 0.070 |
Why?
|
| Neutrophil Infiltration | 2 | 2013 | 390 | 0.070 |
Why?
|
| Iron | 2 | 2014 | 1773 | 0.070 |
Why?
|
| Microglia | 1 | 2015 | 1261 | 0.070 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2011 | 589 | 0.070 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 2566 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2013 | 3862 | 0.070 |
Why?
|
| Time Factors | 8 | 2020 | 40054 | 0.070 |
Why?
|
| Cyclins | 3 | 2004 | 601 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2012 | 8425 | 0.070 |
Why?
|
| Neuroprotective Agents | 1 | 2013 | 941 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 2 | 2014 | 2633 | 0.070 |
Why?
|
| Intestines | 2 | 2013 | 1923 | 0.070 |
Why?
|
| Receptors, Androgen | 2 | 2009 | 1057 | 0.070 |
Why?
|
| Calcium Channels | 1 | 2010 | 621 | 0.070 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 13019 | 0.070 |
Why?
|
| Jurkat Cells | 2 | 2004 | 742 | 0.070 |
Why?
|
| Th2 Cells | 1 | 2011 | 1049 | 0.070 |
Why?
|
| Epithelium | 3 | 2007 | 1680 | 0.070 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 1477 | 0.070 |
Why?
|
| Thermodynamics | 1 | 2007 | 594 | 0.070 |
Why?
|
| Ileus | 1 | 2005 | 58 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 4 | 2016 | 480 | 0.060 |
Why?
|
| Immunophenotyping | 2 | 2020 | 1866 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 3 | 2013 | 3847 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2014 | 2504 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 4 | 2016 | 489 | 0.060 |
Why?
|
| Mixed Function Oxygenases | 1 | 2006 | 272 | 0.060 |
Why?
|
| Propidium | 1 | 2004 | 41 | 0.060 |
Why?
|
| Osteoporosis | 1 | 2014 | 1581 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 2107 | 0.060 |
Why?
|
| Interleukin-12 | 1 | 2007 | 579 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 15108 | 0.060 |
Why?
|
| Models, Biological | 6 | 2019 | 9581 | 0.060 |
Why?
|
| Iliac Artery | 1 | 2006 | 364 | 0.060 |
Why?
|
| Pregnancy Trimester, First | 1 | 2008 | 851 | 0.060 |
Why?
|
| Annexin A5 | 1 | 2004 | 103 | 0.060 |
Why?
|
| Allergens | 2 | 2002 | 1314 | 0.060 |
Why?
|
| Inhalation | 1 | 2004 | 143 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 4465 | 0.060 |
Why?
|
| Peroxidase | 6 | 2005 | 610 | 0.060 |
Why?
|
| Caspase 9 | 1 | 2004 | 188 | 0.060 |
Why?
|
| Hemolysis | 2 | 2018 | 420 | 0.060 |
Why?
|
| Body Weight | 2 | 2014 | 4664 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2013 | 6534 | 0.060 |
Why?
|
| Time | 1 | 2005 | 530 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2006 | 1801 | 0.060 |
Why?
|
| Macrophages, Alveolar | 2 | 2004 | 407 | 0.060 |
Why?
|
| Membrane Potentials | 1 | 2007 | 1135 | 0.060 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2006 | 548 | 0.060 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2004 | 215 | 0.060 |
Why?
|
| Hemodynamics | 4 | 2013 | 4197 | 0.060 |
Why?
|
| Glucose | 2 | 2012 | 4391 | 0.060 |
Why?
|
| Transplantation, Heterologous | 2 | 2002 | 2382 | 0.060 |
Why?
|
| Vasoconstriction | 1 | 2006 | 596 | 0.060 |
Why?
|
| Liver Cirrhosis | 1 | 2013 | 1864 | 0.060 |
Why?
|
| Fractures, Bone | 1 | 2015 | 1945 | 0.050 |
Why?
|
| Hepatitis | 1 | 2004 | 227 | 0.050 |
Why?
|
| Hindlimb | 1 | 2004 | 505 | 0.050 |
Why?
|
| Androgens | 1 | 2010 | 1271 | 0.050 |
Why?
|
| Neoplasm Metastasis | 2 | 2010 | 4839 | 0.050 |
Why?
|
| Hepatic Veno-Occlusive Disease | 1 | 2004 | 220 | 0.050 |
Why?
|
| Organ Specificity | 2 | 2006 | 2003 | 0.050 |
Why?
|
| Growth Inhibitors | 1 | 2004 | 385 | 0.050 |
Why?
|
| Sus scrofa | 3 | 2012 | 437 | 0.050 |
Why?
|
| Lymphocyte Activation | 4 | 2018 | 5519 | 0.050 |
Why?
|
| Plasma Volume | 1 | 2022 | 36 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2014 | 5019 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2007 | 2006 | 0.050 |
Why?
|
| Airway Resistance | 1 | 2003 | 404 | 0.050 |
Why?
|
| Respiration Disorders | 1 | 2005 | 370 | 0.050 |
Why?
|
| Reference Values | 2 | 2002 | 4982 | 0.050 |
Why?
|
| Jejunum | 1 | 2004 | 480 | 0.050 |
Why?
|
| STAT3 Transcription Factor | 1 | 2006 | 874 | 0.050 |
Why?
|
| Female | 19 | 2021 | 379592 | 0.050 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2003 | 319 | 0.050 |
Why?
|
| Aging | 2 | 1998 | 8626 | 0.050 |
Why?
|
| Gastrointestinal Motility | 1 | 2003 | 225 | 0.050 |
Why?
|
| Gene Deletion | 3 | 2019 | 2751 | 0.050 |
Why?
|
| Capillary Permeability | 1 | 2005 | 798 | 0.050 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2006 | 933 | 0.050 |
Why?
|
| Stress, Physiological | 2 | 2007 | 1402 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 2130 | 0.050 |
Why?
|
| Exudates and Transudates | 1 | 2022 | 171 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2012 | 643 | 0.050 |
Why?
|
| Cell Adhesion | 3 | 2015 | 3139 | 0.050 |
Why?
|
| Leukotriene B4 | 2 | 2018 | 293 | 0.050 |
Why?
|
| Multiple Organ Failure | 1 | 2004 | 389 | 0.050 |
Why?
|
| Microscopy, Electron | 2 | 2021 | 2645 | 0.050 |
Why?
|
| Annual Reports as Topic | 1 | 2020 | 33 | 0.050 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2005 | 340 | 0.050 |
Why?
|
| Cardiotonic Agents | 1 | 2004 | 535 | 0.050 |
Why?
|
| Postoperative Complications | 3 | 2017 | 15244 | 0.050 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2015 | 1155 | 0.050 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2007 | 1121 | 0.050 |
Why?
|
| Epithelial Cells | 5 | 2019 | 3678 | 0.050 |
Why?
|
| Response Elements | 1 | 2002 | 311 | 0.050 |
Why?
|
| Chemokine CCL4 | 1 | 2000 | 128 | 0.050 |
Why?
|
| Cognition | 1 | 2017 | 6722 | 0.050 |
Why?
|
| Chromatography, Gel | 1 | 2021 | 668 | 0.050 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2000 | 122 | 0.050 |
Why?
|
| Aged | 9 | 2021 | 162944 | 0.050 |
Why?
|
| Phenylurea Compounds | 2 | 2012 | 526 | 0.050 |
Why?
|
| Pulmonary Artery | 2 | 2006 | 1911 | 0.050 |
Why?
|
| Transcriptional Activation | 3 | 2014 | 1782 | 0.050 |
Why?
|
| Insulin Resistance | 1 | 2014 | 3861 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2013 | 4664 | 0.040 |
Why?
|
| Mitogens | 1 | 2000 | 232 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2019 | 33 | 0.040 |
Why?
|
| Smoking | 2 | 2014 | 8969 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2021 | 2699 | 0.040 |
Why?
|
| Hematologic Tests | 1 | 2020 | 238 | 0.040 |
Why?
|
| Young Adult | 3 | 2021 | 56350 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15530 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2004 | 1907 | 0.040 |
Why?
|
| Gastrointestinal Transit | 3 | 2005 | 96 | 0.040 |
Why?
|
| Intestinal Obstruction | 1 | 2003 | 424 | 0.040 |
Why?
|
| NADH Dehydrogenase | 1 | 2018 | 41 | 0.040 |
Why?
|
| Respiratory System | 1 | 2002 | 555 | 0.040 |
Why?
|
| Gene Expression Profiling | 3 | 2010 | 9410 | 0.040 |
Why?
|
| Actins | 2 | 2023 | 2120 | 0.040 |
Why?
|
| Superoxide Dismutase | 2 | 1999 | 596 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2013 | 3258 | 0.040 |
Why?
|
| Interferon-gamma | 3 | 2005 | 3199 | 0.040 |
Why?
|
| Chemokine CXCL1 | 1 | 2018 | 101 | 0.040 |
Why?
|
| Gene Transfer Techniques | 2 | 2006 | 1224 | 0.040 |
Why?
|
| Cyclooxygenase 1 | 1 | 2018 | 104 | 0.040 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2018 | 222 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 5163 | 0.040 |
Why?
|
| Cyclization | 1 | 2018 | 65 | 0.040 |
Why?
|
| Cryopreservation | 1 | 2003 | 664 | 0.040 |
Why?
|
| Bronchi | 1 | 2002 | 840 | 0.040 |
Why?
|
| Phosphotyrosine | 1 | 2019 | 457 | 0.040 |
Why?
|
| Erythrocyte Count | 1 | 2018 | 163 | 0.040 |
Why?
|
| Vasomotor System | 1 | 1999 | 209 | 0.040 |
Why?
|
| Atrial Fibrillation | 1 | 2017 | 5019 | 0.040 |
Why?
|
| RNA Interference | 1 | 2007 | 2890 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2002 | 794 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2018 | 236 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2013 | 10943 | 0.040 |
Why?
|
| Protein Binding | 3 | 2019 | 9387 | 0.040 |
Why?
|
| Partial Pressure | 1 | 2017 | 253 | 0.040 |
Why?
|
| Click Chemistry | 1 | 2018 | 95 | 0.040 |
Why?
|
| Acetylglucosamine | 1 | 2019 | 191 | 0.040 |
Why?
|
| Staphylococcus aureus | 2 | 2017 | 1449 | 0.040 |
Why?
|
| Electron Transport Complex I | 1 | 2018 | 140 | 0.040 |
Why?
|
| Hydrochloric Acid | 1 | 2017 | 76 | 0.040 |
Why?
|
| Treatment Outcome | 5 | 2018 | 62966 | 0.040 |
Why?
|
| Synaptic Transmission | 1 | 2004 | 1179 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 1434 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2008 | 3920 | 0.040 |
Why?
|
| Urethane | 1 | 1996 | 40 | 0.040 |
Why?
|
| Yohimbine | 1 | 1996 | 62 | 0.040 |
Why?
|
| Hematocrit | 1 | 2018 | 636 | 0.040 |
Why?
|
| Cyclosporine | 1 | 2020 | 784 | 0.040 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2017 | 43 | 0.040 |
Why?
|
| Leukocyte Count | 2 | 2018 | 1583 | 0.040 |
Why?
|
| Mice, Inbred mdx | 1 | 2016 | 90 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2000 | 436 | 0.040 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2009 | 472 | 0.040 |
Why?
|
| Quality Control | 1 | 2019 | 841 | 0.040 |
Why?
|
| Middle Aged | 7 | 2021 | 213127 | 0.040 |
Why?
|
| Abdomen | 1 | 2003 | 1107 | 0.040 |
Why?
|
| Neurons | 2 | 2013 | 9325 | 0.040 |
Why?
|
| Plasma | 1 | 2020 | 575 | 0.040 |
Why?
|
| Drug Tolerance | 1 | 1998 | 375 | 0.040 |
Why?
|
| Ritonavir | 1 | 2018 | 322 | 0.040 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1996 | 174 | 0.040 |
Why?
|
| Disease | 1 | 2002 | 681 | 0.030 |
Why?
|
| Mice, Inbred DBA | 2 | 2007 | 642 | 0.030 |
Why?
|
| Glycosylation | 1 | 2019 | 1123 | 0.030 |
Why?
|
| Cyclin D1 | 2 | 2012 | 462 | 0.030 |
Why?
|
| Pleural Effusion | 1 | 1999 | 338 | 0.030 |
Why?
|
| Adolescent | 2 | 2021 | 85649 | 0.030 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2015 | 55 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 2012 | 4229 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2017 | 6171 | 0.030 |
Why?
|
| Hyperplasia | 2 | 2011 | 1183 | 0.030 |
Why?
|
| Cytosol | 1 | 2018 | 901 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 5724 | 0.030 |
Why?
|
| Acute-Phase Reaction | 1 | 2015 | 91 | 0.030 |
Why?
|
| Prostate | 1 | 2023 | 1764 | 0.030 |
Why?
|
| Collagen | 2 | 2014 | 2684 | 0.030 |
Why?
|
| Thrombosis | 2 | 2007 | 2966 | 0.030 |
Why?
|
| Gentamicins | 2 | 2012 | 253 | 0.030 |
Why?
|
| Fibroblasts | 3 | 2003 | 4143 | 0.030 |
Why?
|
| Bioengineering | 1 | 2016 | 99 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2020 | 804 | 0.030 |
Why?
|
| Muscle Contraction | 3 | 2005 | 1241 | 0.030 |
Why?
|
| Adult | 5 | 2021 | 213712 | 0.030 |
Why?
|
| Anesthetics, General | 1 | 1996 | 152 | 0.030 |
Why?
|
| Liver Diseases | 1 | 2003 | 1252 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2018 | 670 | 0.030 |
Why?
|
| Lung Transplantation | 1 | 2003 | 1155 | 0.030 |
Why?
|
| Ischemia | 1 | 2003 | 1911 | 0.030 |
Why?
|
| Drug Combinations | 2 | 2014 | 1961 | 0.030 |
Why?
|
| DNA, Ribosomal | 1 | 2015 | 289 | 0.030 |
Why?
|
| RNA | 1 | 2004 | 2747 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2012 | 12164 | 0.030 |
Why?
|
| Trachea | 2 | 2017 | 1075 | 0.030 |
Why?
|
| Protein Denaturation | 1 | 2014 | 237 | 0.030 |
Why?
|
| Rotenone | 1 | 2013 | 43 | 0.030 |
Why?
|
| Molybdenum | 1 | 2013 | 46 | 0.030 |
Why?
|
| Maze Learning | 1 | 2015 | 478 | 0.030 |
Why?
|
| Acute Disease | 2 | 2001 | 7141 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2014 | 194 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 2 | 2003 | 77 | 0.030 |
Why?
|
| Muramidase | 1 | 2013 | 174 | 0.030 |
Why?
|
| Laminin | 1 | 2014 | 418 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1780 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2014 | 424 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2007 | 3038 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2015 | 962 | 0.030 |
Why?
|
| Pseudomonas Infections | 1 | 2017 | 608 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2019 | 7901 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2012 | 13814 | 0.030 |
Why?
|
| Regenerative Medicine | 1 | 2016 | 306 | 0.030 |
Why?
|
| Osmolar Concentration | 2 | 2003 | 683 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2020 | 959 | 0.030 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2003 | 329 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 905 | 0.030 |
Why?
|
| Cell Culture Techniques | 2 | 2013 | 1670 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2020 | 2614 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2018 | 765 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2014 | 430 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2015 | 947 | 0.030 |
Why?
|
| Benzenesulfonates | 1 | 2012 | 169 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2017 | 1459 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2015 | 1341 | 0.020 |
Why?
|
| Obesity | 1 | 2014 | 12705 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2014 | 834 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2017 | 12017 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 264 | 0.020 |
Why?
|
| Acetylation | 1 | 2014 | 1085 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2007 | 3428 | 0.020 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2011 | 63 | 0.020 |
Why?
|
| Cadherins | 1 | 2015 | 906 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 2 | 2009 | 3612 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2004 | 4147 | 0.020 |
Why?
|
| RNA, Ribosomal | 1 | 2012 | 246 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2018 | 3913 | 0.020 |
Why?
|
| Heart | 1 | 2004 | 4462 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2014 | 1150 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 2 | 2003 | 611 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2013 | 592 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2013 | 844 | 0.020 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 2010 | 60 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2015 | 1465 | 0.020 |
Why?
|
| Immunity, Mucosal | 1 | 2013 | 491 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 13655 | 0.020 |
Why?
|
| Niacinamide | 1 | 2012 | 416 | 0.020 |
Why?
|
| Microcirculation | 1 | 2015 | 1285 | 0.020 |
Why?
|
| Tyrosine | 1 | 2014 | 1460 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2013 | 689 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 2007 | 10163 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2013 | 674 | 0.020 |
Why?
|
| Muscle, Skeletal | 2 | 2016 | 4933 | 0.020 |
Why?
|
| Dipyridamole | 1 | 2010 | 145 | 0.020 |
Why?
|
| Regional Blood Flow | 2 | 2003 | 1525 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2014 | 6608 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2020 | 53187 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 1937 | 0.020 |
Why?
|
| Immunomodulation | 1 | 2013 | 540 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2017 | 1210 | 0.020 |
Why?
|
| Demography | 1 | 2014 | 1650 | 0.020 |
Why?
|
| Metagenome | 1 | 2012 | 417 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 628 | 0.020 |
Why?
|
| Wound Healing | 2 | 2014 | 2781 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2013 | 1146 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 2014 | 663 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 1372 | 0.020 |
Why?
|
| Anesthesia, General | 1 | 1996 | 1164 | 0.020 |
Why?
|
| General Surgery | 1 | 2020 | 1633 | 0.020 |
Why?
|
| Proteins | 1 | 2004 | 6096 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2014 | 729 | 0.020 |
Why?
|
| Molecular Sequence Data | 4 | 1996 | 18112 | 0.020 |
Why?
|
| Metribolone | 1 | 2008 | 13 | 0.020 |
Why?
|
| Cyclin A1 | 1 | 2008 | 11 | 0.020 |
Why?
|
| Oligopeptides | 1 | 1994 | 1176 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 2505 | 0.020 |
Why?
|
| Quinoxalines | 2 | 2003 | 288 | 0.020 |
Why?
|
| Blotting, Northern | 2 | 2003 | 1581 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2015 | 1599 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2020 | 3740 | 0.020 |
Why?
|
| Erythrocyte Membrane | 1 | 2010 | 442 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 4553 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2013 | 2014 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 2425 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 1144 | 0.020 |
Why?
|
| Survival Rate | 3 | 2004 | 12773 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 2007 | 218 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 1119 | 0.020 |
Why?
|
| Retinal Ganglion Cells | 1 | 2013 | 771 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2010 | 963 | 0.020 |
Why?
|
| Cell Division | 2 | 2006 | 4564 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2012 | 1132 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 2 | 2007 | 1613 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2012 | 1086 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 1969 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2007 | 517 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 1158 | 0.020 |
Why?
|
| Disease Progression | 2 | 2015 | 13256 | 0.020 |
Why?
|
| Computational Biology | 1 | 2018 | 3518 | 0.020 |
Why?
|
| Hemin | 1 | 2006 | 49 | 0.020 |
Why?
|
| Femoral Vein | 1 | 2006 | 159 | 0.020 |
Why?
|
| Antibodies | 1 | 2014 | 2459 | 0.020 |
Why?
|
| Rats, Gunn | 1 | 2005 | 11 | 0.020 |
Why?
|
| Cattle | 2 | 2003 | 3923 | 0.020 |
Why?
|
| Polytetrafluoroethylene | 1 | 2006 | 233 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2012 | 1423 | 0.020 |
Why?
|
| Intracranial Aneurysm | 1 | 2015 | 1197 | 0.020 |
Why?
|
| Leptin | 1 | 2014 | 1593 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2015 | 2066 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2015 | 2452 | 0.020 |
Why?
|
| Complement C3 | 1 | 2007 | 460 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 892 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 12958 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 1749 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 638 | 0.020 |
Why?
|
| Sirolimus | 1 | 2012 | 1562 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 1683 | 0.020 |
Why?
|
| Air | 1 | 2005 | 181 | 0.020 |
Why?
|
| Boston | 1 | 2017 | 9305 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 4200 | 0.020 |
Why?
|
| Transplantation, Isogeneic | 1 | 2004 | 257 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2004 | 16 | 0.020 |
Why?
|
| Nitrites | 1 | 2004 | 160 | 0.020 |
Why?
|
| Binding Sites | 1 | 2013 | 6115 | 0.010 |
Why?
|
| Corrosion Casting | 1 | 2003 | 15 | 0.010 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2004 | 101 | 0.010 |
Why?
|
| Interferon Regulatory Factors | 1 | 2005 | 270 | 0.010 |
Why?
|
| Bethanechol | 1 | 2003 | 13 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2017 | 2789 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2003 | 33 | 0.010 |
Why?
|
| Renal Circulation | 1 | 2004 | 333 | 0.010 |
Why?
|
| Oxadiazoles | 1 | 2003 | 93 | 0.010 |
Why?
|
| Mice, Inbred A | 1 | 2003 | 248 | 0.010 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2004 | 148 | 0.010 |
Why?
|
| Enterocytes | 1 | 2005 | 225 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2014 | 2575 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 2004 | 321 | 0.010 |
Why?
|
| Enteritis | 1 | 2004 | 160 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2016 | 2536 | 0.010 |
Why?
|
| NADP | 1 | 2004 | 225 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 2004 | 425 | 0.010 |
Why?
|
| Nitrates | 1 | 2004 | 265 | 0.010 |
Why?
|
| Bronchoconstriction | 1 | 2003 | 141 | 0.010 |
Why?
|
| Linear Models | 1 | 2013 | 5948 | 0.010 |
Why?
|
| Asthma | 1 | 2001 | 5955 | 0.010 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2003 | 281 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1675 | 0.010 |
Why?
|
| Femoral Artery | 1 | 2006 | 843 | 0.010 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2004 | 261 | 0.010 |
Why?
|
| Permeability | 1 | 2004 | 738 | 0.010 |
Why?
|
| Adenosine Monophosphate | 1 | 2004 | 276 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 2004 | 683 | 0.010 |
Why?
|
| I-kappa B Proteins | 1 | 2002 | 225 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2906 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2012 | 5454 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2003 | 718 | 0.010 |
Why?
|
| Pressure | 1 | 2005 | 1203 | 0.010 |
Why?
|
| Research Design | 1 | 2017 | 5979 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 4379 | 0.010 |
Why?
|
| Colitis, Ulcerative | 1 | 2013 | 1901 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2005 | 1902 | 0.010 |
Why?
|
| Bone Density | 1 | 2014 | 3469 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 2892 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1997 | 8541 | 0.010 |
Why?
|
| Electric Countershock | 1 | 2004 | 535 | 0.010 |
Why?
|
| bcl-Associated Death Protein | 1 | 2001 | 107 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2005 | 1056 | 0.010 |
Why?
|
| Endothelium | 1 | 2003 | 778 | 0.010 |
Why?
|
| Pyridines | 1 | 2012 | 2818 | 0.010 |
Why?
|
| NAD | 1 | 2004 | 594 | 0.010 |
Why?
|
| Base Sequence | 3 | 1996 | 12797 | 0.010 |
Why?
|
| Edema | 1 | 2004 | 790 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2000 | 192 | 0.010 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2005 | 576 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2005 | 2723 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 2005 | 1126 | 0.010 |
Why?
|
| Tetracycline | 1 | 2000 | 214 | 0.010 |
Why?
|
| Eicosanoids | 1 | 2001 | 278 | 0.010 |
Why?
|
| Necrosis | 1 | 2004 | 1643 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2001 | 719 | 0.010 |
Why?
|
| Blood Cells | 1 | 2001 | 309 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 6891 | 0.010 |
Why?
|
| Insulin | 1 | 2014 | 6575 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2005 | 1869 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2004 | 2187 | 0.010 |
Why?
|
| Dinoprostone | 1 | 2001 | 600 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2004 | 994 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 12344 | 0.010 |
Why?
|
| Phenylephrine | 1 | 1999 | 301 | 0.010 |
Why?
|
| Age Factors | 1 | 2015 | 18355 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 2001 | 800 | 0.010 |
Why?
|
| Xylazine | 1 | 1996 | 10 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 3502 | 0.010 |
Why?
|
| Colon | 1 | 2005 | 1773 | 0.010 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2006 | 1384 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2003 | 1484 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1999 | 1420 | 0.010 |
Why?
|
| Eosinophils | 1 | 2001 | 953 | 0.010 |
Why?
|
| Survival | 1 | 1996 | 162 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2005 | 6365 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 1996 | 226 | 0.010 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1996 | 177 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 57683 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1996 | 462 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 1999 | 643 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 1636 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 77098 | 0.010 |
Why?
|
| Quality of Life | 1 | 2016 | 12730 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 16331 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1995 | 286 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2003 | 2245 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1995 | 862 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1995 | 286 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2003 | 3420 | 0.010 |
Why?
|
| Nuclear Proteins | 2 | 2001 | 5851 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2004 | 3038 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1995 | 575 | 0.010 |
Why?
|
| United States | 1 | 2020 | 69693 | 0.010 |
Why?
|
| Albumins | 1 | 1995 | 568 | 0.010 |
Why?
|
| Prognosis | 1 | 2013 | 29010 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2003 | 2117 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2014 | 40450 | 0.010 |
Why?
|
| Genes | 1 | 1995 | 1892 | 0.010 |
Why?
|
| Creatinine | 1 | 1996 | 1916 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2001 | 2941 | 0.010 |
Why?
|
| Cell Count | 1 | 1994 | 1831 | 0.010 |
Why?
|
| Analgesics, Opioid | 1 | 2005 | 3667 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1995 | 1337 | 0.010 |
Why?
|
| Child | 1 | 2016 | 77478 | 0.010 |
Why?
|
| Feces | 1 | 1993 | 1394 | 0.000 |
Why?
|
| Pregnancy | 1 | 2008 | 29087 | 0.000 |
Why?
|
| DNA Mutational Analysis | 1 | 1995 | 4187 | 0.000 |
Why?
|
| Environmental Exposure | 1 | 2001 | 4231 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 1996 | 7721 | 0.000 |
Why?
|